PURPOSE: To (a) validate a breast magnetic resonance (MR) interpretation mo
del, (b) expand the tree-shaped prediction model to increase specificity wi
thout decreasing sensitivity, and (c) reevaluate the model's diagnostic per
formance.
MATERIALS AND METHODS: Two hundred sixty-two new patients with palpable or
mammographic abnormalities underwent MR imaging, and pathologic evaluation
was performed. They were entered prospectively into the model, which yielde
d 454 patients in the construction (training) and validation (test) phases.
Predictive values for previously published terminal nodes or branch points
of the model were compared between he training and test data sets. Ductal
enhancement morphology, regional enhancement micronodularity, regional enha
ncement degree, and focal mass T2 signal intensity were evaluated for model
expansion. Diagnostic performance characteristics of the model were recalc
ulated.
RESULTS: For Previously published nodes, absence of a lesion visible at MR
imaging, smooth masses, lobulated masses with nonenhancing internal septati
ons, and lobulated masses with minimal or no enhancement had negative predi
ctive values (NPVs) for malignancy similar in both data sets (96% us 99%, 1
00% vs 93%, 100% vs 98%, and 100% vs 100%). Irregular masses with internal
septation (100% vs 0%) and spiculated masses with no or minimal enhancement
(100% vs 50%) did not. Nonseptated enhancing lobulated masses with low T2
signal intensity were added as a benign terminal node (NPV, 100%). Mild reg
ional enhancement (NPV, 92%) was added but not considered a terminal node.
Sensitivity, specificity, NPV, positive predictive value, and accuracy of t
he expanded model were 96%, 80%, 96%; 78%, and 87%, respectively.
CONCLUSION: Additional investigation yielded a slightly modified model, but
the diagnostic performance characteristics remain high, similar to those o
riginally published.